The Valley Desk

NCT02207465 · Interventional trial

A Phase I Dual Dose Escalation Study of Radiation and Nab-Paclitaxel in Patients With Unresectable and Borderline Resectable Pancreatic Cancer

Overall registry status Active not recruiting

Phase 1

Conditions Borderline Resectable Pancreatic Cancer Treated With Chemoradiotherapy, Locally Advanced Unresectable Pancreatic Cancer Treated With Chemoradiotherapy

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov